养阴活血通络明目合剂治疗2型糖尿病并视网膜病变的临床研究

《养阴活血通络明目合剂治疗2型糖尿病并视网膜病变的临床研究》由会员上传分享，免费在线阅读，更多相关内容在学术论文-天天文库。

1、提要目的：观察养阴活血通络明目合剂对2型糖尿病并视网膜病变的影响。方法：本研究纳入的60例2型糖尿病并视网膜病变的患者均来自山东中医药大学附属医院内分泌科门诊及病房。随机将其分为两个组：对照组30例给予基础治疗，即在标准的饮食和运动计划基础上，给予芪明颗粒治疗；治疗组30例在上述基础治疗基础上，给予养阴活血通络明目合剂，4个周为一个疗程，连续服用二个疗程。结果：经过临床研究，治疗组与对照组在降低血糖水平以及改善糖化血红蛋白上均有疗效，但治疗组的疗效明显优于对照组（P<0.01）；在改善视网膜病变疗效以及血流变指标方面优于对照组（P<0.05），并且在治疗过程中未发

2、生不良反应。结论：临床观察表明，养阴活血通络明目合剂治疗2型糖尿病并视网膜病变有明显的临床疗效，在改善患者的血糖、血脂、血液流变学指标方面也起到了积极的作用，且在治疗过程中未发生明显的不良反应，值得进一步研究。关键词2型糖尿病并视网膜病变；养阴活血通络明目合剂；临床研究ClinicalStudyonTreatmentoftype2DiabeticandRetinopathy(DR)withYangyinhuoxuetongluomingmuMixtureSpeciality:InternalMedicineofTCMAuthor:LiuXiaoTutor:Prof

3、essorGuoBaorongAbstractObjective:ToobservetheeffectofYangyinhuoxuetongluomingmumixtureintreatingtype2diabeticandretinopathy(DR).Methods:The60patientswithDRincludedinthisstudywereallfromShandongUniversityofTraditionalChineseMedicineSubsidiaryHospitalendocrinologyoutpatientandhospitalwa

4、rd.Randomlydividedintotwogroups,30patientsweregivenfoundationtreatment,thatwereonthebasisoftheStandarddietandexerciseprogram,giventhetreatmentofQiMinggranule.Theother30patientsinthefoundationtreatmentonthebasisofgivingYangyinhuoxuetongluomingmumixture.Oneprocessoftreatmentlastedfor4we

5、eks,and8weekswereneeded.Results:Afterclinicalobservation,treatmentgroupandcontrolgrouphadthecurativeeffectonloweringbloodglucoselevelsandimprovingthesymptomsofretinopathy,buttheeffectoftreatmentgroupwasmuchbetterthanthecontrolgroup（P<0.05）;thetreatmentgroupwasalsobetterthancontrolgrou

6、pinimprovingglycosylatedhemoglobin,bloodlipid,bloodrheologyindicators（P<0.05）,andnoadversereactionsoccurredinthecourseoftreatment.Conclusions:clinicalobservationsshowthat,yangyinhuoxuetongluomingmumixturehadobviousadvantagesintreatingDR,playedanactiveroleinimprovingbloodglucose,bloodl

7、ipid,bloodrheology,andnoadversereactionsoccurredinthecourseoftreatment.Itisworthstudyingdeeplyanddevelopingfurther.KeyWordstype2diabeticandretinopathy(DR);yangyinhuoxuetongluomingmumixture;clinicalresearch目录引言............................................................................

8、.....